(MedPage Today) — SAN FRANCISCO — For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
Following the…
Source link : https://www.medpagetoday.com/meetingcoverage/tct/118208
Author :
Publish date : 2025-10-29 16:42:00
Copyright for syndicated content belongs to the linked Source.
